1. A RIDDLE WRAPPED IN A MYSTERY INSIDE AN ENIGMA: NHSN SURVEILLANCE DEFINITIONS MSIPC Fall 2015 Interactive Breakout Session Allison Murad, MPH Michigan Department of Health and Human Services

2. Disclosures I have nothing to disclose

3. Interactive Session Quick review of surveillance definitions and changes Real case studies sent from hospitals like yours!

4. Reporting Reminders Always refer to the protocol! For NHSN reporting, surveillance determinations “trump” clinical judgement Clinical diagnoses are important for treatment of individual patients Surveillance definitions are important in identifying trends within a population Concerns should be sent to nhsn@cdc.gov instead of not reporting or facility adjudicationnhsn@cdc.gov

5. CMS Reporting Review CLABSI: Adult, Pediatric, and Neonatal ICUs; Adult and Pediatric Medical, Surgical, and Medical/Surgical Wards CAUTI: Adult and Pediatric ICUs; Adult and Pediatric Medical, Surgical, and Medical/Surgical Wards SSI: COLO and HYST Procedures MDRO/CDI: MRSA Bacteremia and CDI LabID (FacWideIn, ED, Obs)

6. CMS Reporting Review Medicare Beneficiary Number for all Medicare patients reported into NHSN Healthcare Personnel Influenza Vaccination data for all Inpatient Healthcare Personnel

7. NHSN DEFINITIONS

8. POA vs. HAI Present on Admission (POA): date of event occurs on the day of admission or the day after admission (day of admission, 2 days before, day after) Healthcare-Associated Infection (HAI): date of event occurs on or after the 3 rd calendar day of admission

9. New in 2015 DOE: Date of Event (Not for VAE or LabID). Date the first element used to meet the CDC NHSN site-specific infection criterion occurs for the first time within the seven day infection window period Infection Window Period (Not for SSI, VAE, or LabID): a seven day period during which all site-specific infection criterion must be met. It includes the date of the first positive diagnostic test that is an element of the site- specific criterion, 3 calendar days before and 3 calendar days after

10. New in 2015 Repeat Infection Timeframe (RIT) (Not for SSI, VAE, or LabID): 14-day period during which repeat infections of the same type will not be reported to NHSN. If additional site- specific specimens are collected within the RIT and new pathogens are identified, those pathogens should be added to the original infection. Secondary BSI Attribution Period (Not for SSI, VAE, or LabID): time period during which a BSI can be attributed as secondary to another infection site, if all other required guidelines (i.e. Secondary BSI Guideline) are met. The time period will include the IWP of the primary infection as well as that infection’s RIT and will vary from 14-17 days depending on date of event.

11. No Longer Used in NHSN Surveillance Gap Days concept to determine criterion met Logical pathogens to determine secondary BSI Date of Event = Date of last element

12. CLABSI

13. CLABSI Reporting – New in 2015 Report CLABSI from all adult, pediatric, and neonatal: ICUs Medical Wards Surgical Wards Medical/Surgical Wards

14. BSI Key Term Central Line: Intravascular catheter that terminates at or close to the heart or in one of the great vessels which is used for infusion, withdrawal of blood, or hemodynamic monitoring (femoral arteries are not great vessels)

15. CLABSI Definition

16. LCBI 1 and LCBI 2

17. LCBI 3

18. Secondary BSI In order for a bloodstream infection to be determined to be secondary to a primary infection site, the patient must meet all three below: Meet one of the NHSN site-specific definitions Have a positive blood culture within the Secondary BSI Attribution Period Meet requirements in Secondary BSI Scenario 1 or 2

19. Secondary BSI Scenarios Scenario 1: Blood and site-specific specimen cultures match for at least one organism Scenario 2: Blood and site-specific specimen cultures do not match If the blood isolate is an element used to meet the site-specific criterion, then the BSI is considered secondary to that site-specific infection If the site-specific culture is an element used to meet the infection site criterion and the blood isolate is not, then the BSI is considered a primary infection

20. CAUTI

21. CAUTI Reporting – New in 2015 Report CAUTI from all adult and pediatric: ICUs Medical Wards Surgical Wards Medical/Surgical Wards

22. UTI Key Terms Indwelling Catheter: A drainage tube that is inserted into the urinary bladder through the urethra, is left in place, and is connected to a drainage bag (including leg bags). These devices are also called Foley catheters. Condom or straight in-and-out catheters are not included nor are nephrostomy tubes, ileoconduits, or suprapubic catheters unless a Foley catheter is also present. Indwelling urethral catheters that are used for intermittent or continuous irrigation are included in CAUTI surveillance.

23. Types of UTIs Symptomatic UTI (SUTI) SUTI 1: Any age SUTI 1a: Catheter-associated SUTI 1b: Non-catheter-associated SUTI 2: Infants ≤1 year, with or without indwelling urinary catheter Asymptomatic Bacteremic UTI (ABUTI) Any Age, with or without indwelling urinary catheter

24. SUTI 1a

25. SUTI 1b

26. SUTI 2 and ABUTI

27. SSI

28. No new CMS reporting in 2015 New Key Term: PATOS (infection present at time of surgery) PATOS denotes that there is evidence of an infection or abscess at the start of or during the index surgical procedure (in other words, it is present preoperatively). PATOS is a YES/NO field on the SSI Event form. PATOS does not apply if there is a period of wellness between the time of a preoperative condition and surgery. The evidence of infection or abscess must be noted/documented preoperatively or found intraoperatively in a pre-operative or intraoperative note. Only select PATOS = YES if it applies to the depth of SSI that is being attributed to the procedures (e.g., if a patient had evidence of an intraabdominal infection at the time of surgery and then later return with an organ space SSI the PATOS field would be selected as a YES. If the patient returned with a superficial or deep incisional SSI the PATOS field would be selected as a NO). The patient does not have to meet the NHSN definition of an SSI at the time of the primary procedure but there must be notation that there is evidence of an infection or abscess present at the time of surgery.

29. SSI Key Term NHSN Operative Procedure is a procedure: That is included in Table 1 (list of procedure types) Takes place during an operation where at least one incision (including laparoscopic approach) is made through the skin or mucous membrane, or reoperation via an incision that was left open during a prior operative procedure Takes place in an operating room (OR), defined as a patient care area that met the Facilities Guidelines Institute’s (FGI) or American Institute of Architects’ (AIA) criteria for an operating room when it was constructed or renovated. This may include an operating room, C-section room, interventional radiology room, or a cardiac catheterization lab.

30. Superficial Incisional SSI

31. Deep Incisional SSI

32. Organ/Space SSI

33. MRSA/CDI LABID

34. MRSA/CDI New in 2015: Report MRSA bacteremia LabID and CDI LabID from Emergency Departments and 24 hour Observation units Note: This will auto-populate when you add FacWideIn reporting to your reporting plan and have ED or OBS locations

35. Key Terms Laboratory-Identified (LabID) Event: All non-duplicate MDRO isolates from any specimen source and unique blood source MDRO isolates. [EXCLUDES tests related to active surveillance testing]. Even if reporting at the FacWide level, all reporting must follow rules by location for reporting.

36. Definitions MRSA: Includes S. aureus cultured from any specimen that tests oxacillin-resistant, cefoxitin-resistant, or methicillin-resistant by standard susceptibility testing methods, or by a laboratory test that is FDA-approved for MRSA detection from isolated colonies; these methods may also include a positive result by any FDA-approved test for MRSA detection from specific sources.

37. Definitions CDI-positive laboratory assay: A positive laboratory test result for C. difficile toxin A and/or B, (includes molecular assays [PCR] and/or toxin assays) tested on an unformed stool specimen (must conform to the container) OR: A toxin-producing C. difficile organism detected by culture or other laboratory means performed on an unformed stool sample (must conform to the container).

38. Definitions Duplicate C. difficile-positive test: Any C. difficile toxin- positive laboratory result from the same patient and location, following a previous C. difficile toxin-positive laboratory result within the past two weeks [14 days] (even across calendar months and readmissions to the same facility). There should be 14 days with no C. difficile toxin-positive laboratory result for the patient and location before another C. difficile LabID Event is entered into NHSN for the patient and location. The date of specimen collection is considered Day 1.

39. Key Terms MRSA and CDI: Community-Onset (CO): LabID Event specimen collected in an outpatient location or an inpatient location ≤3 days after admission to the facility (i.e., days 1, 2, or 3 of admission). MRSA and CDI: Healthcare Facility-Onset (HO): LabID Event specimen collected >3 days after admission to the facility (i.e., on or after day 4). CDI Only: Community-Onset Healthcare Facility-Associated (CO-HCFA): CO LabID Event collected from a patient who was discharged from the facility ≤4 weeks prior to current date of stool specimen collection. Data from outpatient locations (e.g., outpatient encounters) are not included in this definition.

40. VAE

41. VAE: VAEs are identified by using a combination of objective criteria: deterioration in respiratory status after a period of stability or improvement on the ventilator, evidence of infection or inflammation, and laboratory evidence of respiratory infection. NOTE: Patients must be mechanically ventilated for more than 2 calendar days to be eligible for VAE. The earliest day on which VAE criteria can be fulfilled is day 4 of mechanical ventilation (where the day of intubation and initiation of mechanical ventilation is day 1). The earliest date of event for VAE (the date of onset of worsening oxygenation) is day 3 of mechanical ventilation.

42. Key Terms Date of event: The date of onset of worsening oxygenation. This is defined as the first calendar day in which the daily minimum PEEP or FiO2 increases above the thresholds outlined in the VAE definition algorithm (i.e., day 1 of the required ≥ 2-day period of worsening oxygenation following a ≥ 2-day period of stability or improvement on the ventilator).

43. Key Terms VAE Window Period: This is the period of days around the event date (i.e., the day of onset of worsening oxygenation) within which other VAE criteria must be met. It is usually a 5-day period and includes the 2 days before, the day of, and the 2 days after the VAE event date (i.e., the first day of worsening oxygenation, the day of VAE onset). There is an exception, however, in which the VAE Window Period is only 3 or 4 days, as follows: In cases where the VAE event date corresponds to MV day 3 or day 4, the window period described above may only be a 3-day or a 4-day window, because it can NOT include any days before the 3rd day of MV. For example, if the VAE event date is MV day 3, then the window period includes only the day of VAE onset and the 2 days after VAE onset (because the 2 days before VAE onset are before the 3rd day of MV).

44. WHAT WILL BE NEW IN 2016?

45. 2016 Changes Will be officially released November 2015 Don’t see many major changes Will go into effect January 1, 2016

46. Glimpse into 2016 Changes Changes will address: Positive blood cultures associated with observed or suspected patient access of vascular access lines that is documented in the medical record The use of non-culture diagnostic test results in place of culture results for NHSN HAI surveillance The classification of infections with community-associated fungal pathogens as HAIs

47. Glimpse into 2016 Changes Positive cultures collected from patients declared brain dead and awaiting organ harvesting for donation Symptoms of infection at non-central line vascular access sites with concurrent positive blood cultures Respiratory specimen types used for PNU3 criteria BSIs reported with enteric organisms such as Salmonella

48. Thank you! Allie Murad, MPH Michigan Department of Health and Human Services SHARP Unit murada@michigan.gov www.michigan.gov/hai Join us for Michigan NHSN User Group Calls every other month! Next Call: Wednesday, November 18 th at 10am